These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28487942)

  • 1. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
    Yue G; Chen C; Bai L; Wang G; Huang Y; Wang Y; Cui H; Xiao Y
    Mol Med Rep; 2019 Nov; 20(5):4551-4557. PubMed ID: 31702026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.
    Chuang MJ; Sun KH; Tang SJ; Deng MW; Wu YH; Sung JS; Cha TL; Sun GH
    Cancer Sci; 2008 May; 99(5):905-13. PubMed ID: 18294286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency.
    Zhou H; Guo L; Yao W; Shi R; Yu G; Xu H; Ye Z
    J Cell Physiol; 2020 Mar; 235(3):2113-2128. PubMed ID: 31432508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
    Zhao L; Quan J; Li Z; Pan X; Wang J; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Chen Y; Lai Y
    Int J Mol Med; 2019 Jan; 43(1):525-534. PubMed ID: 30320376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR2/Snail-1-Induced Epithelial-Mesenchymal Transition in the Formation and Progression of RCC with Inferior Vena Cava Tumour Thrombus.
    Wang L; Gao J; Zheng S; Luo Z; Xu Z; Che H; Wang Z
    Arch Esp Urol; 2024 Apr; 77(3):292-302. PubMed ID: 38715171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma.
    Ni C; Guo Z; Bu H; Zhao X; Bao M; Ding L; Liang C; Tang Q; Li J
    Chem Biol Interact; 2024 Jul; 397():111092. PubMed ID: 38825053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
    Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
    Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CALCR exacerbates renal cell carcinoma progression via stabilizing CD44.
    Yan H; Xing Z; Liu S; Gao P; Wang Q; Guo G
    Aging (Albany NY); 2024 Jul; 16(13):10765-10783. PubMed ID: 38985127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma.
    Zhou D; Kannappan V; Chen X; Li J; Leng X; Zhang J; Xuan S
    Exp Mol Med; 2016 Jun; 48(6):e238. PubMed ID: 27282106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress of m
    Zhang Y; Cao ZF; Zhang YS
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):876-882. PubMed ID: 39103278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression.
    Huynh TP; Barwe SP; Lee SJ; McSpadden R; Franco OE; Hayward SW; Damoiseaux R; Grubbs SS; Petrelli NJ; Rajasekaran AK
    PLoS One; 2015; 10(4):e0122442. PubMed ID: 25836370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cancer secretome induces migration of mesenchymal stromal cells.
    Popławski P; Zarychta-Wiśniewska W; Burdzińska A; Bogusławska J; Adamiok-Ostrowska A; Hanusek K; Rybicka B; Białas A; Kossowska H; Iwanicka-Nowicka R; Koblowska M; Pączek L; Piekiełko-Witkowska A
    Stem Cell Res Ther; 2023 Aug; 14(1):200. PubMed ID: 37563650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of tumor spheroids in a 3D microphysiological renal cell carcinoma-on-a-chip system.
    Miller CP; Fung M; Jaeger-Ruckstuhl CA; Xu Y; Warren EH; Akilesh S; Tykodi SS
    Neoplasia; 2023 Dec; 46():100948. PubMed ID: 37944353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the molecular mechanisms driving metastasis.
    Massagué J; Batlle E; Gomis RR
    Mol Oncol; 2017 Jan; 11(1):3-4. PubMed ID: 28085221
    [No Abstract]   [Full Text] [Related]  

  • 17. AF9 targets acetyl-modified STAT6 to diminish purine metabolism and accelerate cell apoptosis during metastasis.
    Shao J; Shi T; Chen L; Wang X; Yu H; Feng N; Wang X
    Cell Death Differ; 2023 Jul; 30(7):1695-1709. PubMed ID: 37308587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood Eosinophil and Basophil Values Before and After Surgery for Eosinophilic-type Sinonasal Polyps.
    Brescia G; Parrino D; Zanotti C; Tealdo G; Barion U; Sfriso P; Marioni G
    Am J Rhinol Allergy; 2018 May; 32(3):194-201. PubMed ID: 29676185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin regulates astrocyte gliotransmission and modulates behavior.
    Cai W; Xue C; Sakaguchi M; Konishi M; Shirazian A; Ferris HA; Li ME; Yu R; Kleinridders A; Pothos EN; Kahn CR
    J Clin Invest; 2018 Jul; 128(7):2914-2926. PubMed ID: 29664737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cholesterol lowering in an AngII‑infused atherosclerotic mouse model with moderate hypercholesterolemia.
    Rossignoli A; Vorkapic E; Wanhainen A; Länne T; Skogberg J; Folestad E; Wågsäter D
    Int J Mol Med; 2018 Jul; 42(1):471-478. PubMed ID: 29658561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.